ENDRA Life Sciences Statistics
Total Valuation
NDRA has a market cap or net worth of $6.34 million. The enterprise value is $6.44 million.
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NDRA has 1.27 million shares outstanding. The number of shares has increased by 178.72% in one year.
| Current Share Class | 1.27M |
| Shares Outstanding | 1.27M |
| Shares Change (YoY) | +178.72% |
| Shares Change (QoQ) | +8.03% |
| Owned by Insiders (%) | 5.58% |
| Owned by Institutions (%) | 7.06% |
| Float | 1.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.46 |
| P/TBV Ratio | 3.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.64, with a Debt / Equity ratio of 0.26.
| Current Ratio | 0.64 |
| Quick Ratio | 0.43 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -412.60% and return on invested capital (ROIC) is -176.20%.
| Return on Equity (ROE) | -412.60% |
| Return on Assets (ROA) | -122.33% |
| Return on Invested Capital (ROIC) | -176.20% |
| Return on Capital Employed (ROCE) | -248.49% |
| Weighted Average Cost of Capital (WACC) | 3.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$663,865 |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.22% in the last 52 weeks. The beta is -0.04, so NDRA's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | +44.22% |
| 50-Day Moving Average | 5.09 |
| 200-Day Moving Average | 4.92 |
| Relative Strength Index (RSI) | 50.19 |
| Average Volume (20 Days) | 47,450 |
Short Selling Information
The latest short interest is 19,820, so 1.56% of the outstanding shares have been sold short.
| Short Interest | 19,820 |
| Short Previous Month | 32,603 |
| Short % of Shares Out | 1.56% |
| Short % of Float | 1.65% |
| Short Ratio (days to cover) | 1.18 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.47M |
| Pretax Income | -7.30M |
| Net Income | -7.30M |
| EBITDA | -6.43M |
| EBIT | -6.47M |
| Earnings Per Share (EPS) | -$7.71 |
Full Income StatementBalance Sheet
The company has $356,462 in cash and $461,206 in debt, giving a net cash position of -$104,744 or -$0.08 per share.
| Cash & Cash Equivalents | 356,462 |
| Total Debt | 461,206 |
| Net Cash | -104,744 |
| Net Cash Per Share | -$0.08 |
| Equity (Book Value) | 1.79M |
| Book Value Per Share | 1.44 |
| Working Capital | -298,774 |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.01M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 39,751 |
| Net Borrowing | n/a |
| Free Cash Flow | -5.01M |
| FCF Per Share | -$3.94 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |